首脑会议
医学
阶段(地层学)
肺癌
肿瘤科
内科学
地图学
古生物学
生物
地理
作者
Ruth Prendecki,Amyn Bhamani,Priyam Verghese,Andrew Creamer,Chuen Ryan Khaw,Monica Mullin,Helen Hall,Jennifer Dickson,Carolyn Horst,Sophie Tisi,Kylie Gyertson,Alex Hacker,Laura Farrelly,John P. McCabe,Arjun Nair,Allan Hackshaw,Sam M. Janes
出处
期刊:Lung Cancer
[Elsevier]
日期:2024-04-01
卷期号:190: 107733-107733
标识
DOI:10.1016/j.lungcan.2024.107733
摘要
Small cell lung cancer (SCLC) accounts for 15% of lung cancers with 30% of diagnoses at limited stage and 70% at extensive stage. The median survival is 15 and 6.2 months for limited and extensive stage SCLC respectively. Low dose Computed Tomography (LDCT) screening has not typically been thought to provide a survival benefit in SCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI